Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOLEDO: Tapering Abatacept or Tocilizumab in RA
NCT01557374Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2012
- Primary completion
- Nov 2019
- Modality
- Antibody Conjugates, Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept, tocilizumab in rheumatoid arthritis (RA), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2012; status: completed.
02
Drugs
abatacepttocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01557374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557374.